University of Pennsylvania

ScholarlyCommons
Departmental Papers (Dental)

Penn Dental Medicine

12-15-2000

Chemokine Production by G Protein-Coupled Receptor Activation
in a Human Mast Cell Line: Roles of Extracellular Signal-Regulated
Kinase and NFAT
H. Ali
University of Pennsylvania

J. Ahamed
University of Pennsylvania

C. Hernandez-Munain
University of Pennsylvania

J. L. Baron
University of Pennsylvania

M. S. Krangel
University of Pennsylvania

See next page for additional authors
Follow this and additional works at: https://repository.upenn.edu/dental_papers
Part of the Dentistry Commons

Recommended Citation
Ali, H., Ahamed, J., Hernandez-Munain, C., Baron, J. L., Krangel, M. S., & Patel, D. D. (2000). Chemokine
Production by G Protein-Coupled Receptor Activation in a Human Mast Cell Line: Roles of Extracellular
Signal-Regulated Kinase and NFAT. Journal of Immunology, 165 (12), 7215-7223. http://dx.doi.org/
10.4049/jimmunol.165.12.7215

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/dental_papers/441
For more information, please contact repository@pobox.upenn.edu.
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Abstract
Chemoattractants are thought to be the first mediators generated at sites of bacterial infection. We
hypothesized that signaling through G protein-coupled chemoattractant receptors may stimulate cytokine
production. To test this hypothesis, a human mast cell line (HMC-1) that normally expresses receptors for
complement components C3a and C5a at low levels was stably transfected to express physiologic levels
of fMLP receptors. We found that fMLP, but not C3a or C5a, induced macrophage inflammatory protein
(MIP)-1β (CCL4) and monocyte chemoattractant protein-1 (CCL2) mRNA and protein. Although fMLP
stimulated both sustained Ca2+ mobilization and phosphorylation of extracellular signal-regulated kinase
(ERK), these responses to C3a or C5a were transient. However, transient expression of C3a receptors in
HMC-1 cells rendered the cells responsive to C3a for sustained Ca2+ mobilization and MIP-1β production.
The fMLP-induced chemokine production was blocked by pertussis toxin, PD98059, and cyclosporin A,
which respectively inhibit G(iα) activation, mitgen-activated protein kinase kinase-mediated ERK
phosphorylation, and calcineurin-mediated activation of NFAT. Furthermore, fMLP, but not C5a, stimulated
NFAT activation in HMC-1 cells. These data indicate that chemoattractant receptors induce chemokine
production in HMC-1 cells with a selectivity that depends on the level of receptor expression, the length of
their signaling time, and the synergistic interaction of multiple signaling pathways, including extracellular
signal-regulated kinase phosphorylation, sustained Ca2+ mobilization and NFAT activation.
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C

hemoattractants, such as formyl containing bacterial peptides (for example, fMLP), and the complement components C3a and C5a (1–3) are among the first mediators
generated at sites of bacterial infection. These chemoattractants
activate leukocyte chemotaxis and cause mediator release via their
interaction with cell surface G protein-coupled receptors (GPCR).4
fMLP causes the generation of superoxide anions and stimulates
the production of IL-8 (CXCL8) in neutrophils and monocytes (4,
5). We hypothesized that leukocytes probably produce other proinflammatory cytokines in response to stimulation by
chemoattractants.
The signaling pathways and biological responses activated by
fMLP and C5a receptors (FR and C5aR) have been studied in the
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most detail in human neutrophils. However, very little information
is available on the signaling pathways activated by C3aR. In neutrophils, both FR and C5aR couple to the same pertussis toxin
(ptx)-sensitive G proteins to activate similar biological responses,
such as superoxide generation and the release of proteolytic enzymes (3, 6, 7). The biochemical events that follow FR and C5aR
activation in neutrophils include the activation of phospholipase C,
phosphoinositol 3-kinase (PI3 kinase), increased association of Src
family of protein kinases with p21ras, and activation of p42/p44
mitogen-activated protein kinases (MAPK), known as extracellular
signal-regulated kinases (ERKs) (6, 8, 9). The transcription factor
NF-B is activated by fMLP and C5a in neutrophils, and this activation is associated with IL-8 production (4, 5). The transcription
factor NFAT regulates the activation of cytokine genes in Agstimulated T cells and mast cells (10, 11). Whether NFAT is activated by GPCR in leukocytes and what biological response it
performs are not known.
The purpose of the present study was to determine whether
GPCRs could activate the production of cytokines and to delineate
the signaling pathways involved in this process. We have used a
human mast cell line, HMC-1 cells, which is a rich source of
chemokines (12), as a model for GPCR activation. Although this
cell line natively expresses C3aR and C5aR at low levels, it does
not express FR. Therefore, we developed this cell line to stably
express physiologic levels of FR. We found that fMLP stimulated
a sustained Ca2⫹ mobilization, whereas the responses to C3a or
C5a were transient. Using this system, we demonstrate that fMLP
induces the expression and release of the chemokines macrophage
inflammatory protein (MIP)-1␤ and monocyte chemoattractant
protein (MCP)-1. Furthermore, we have dissected the signaling
pathways activated by GPCRs in HMC-1 cells and made the novel
observations that their ability to stimulate chemokine production
0022-1767/00/$02.00
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Chemoattractants are thought to be the first mediators generated at sites of bacterial infection. We hypothesized that signaling
through G protein-coupled chemoattractant receptors may stimulate cytokine production. To test this hypothesis, a human mast
cell line (HMC-1) that normally expresses receptors for complement components C3a and C5a at low levels was stably transfected
to express physiologic levels of fMLP receptors. We found that fMLP, but not C3a or C5a, induced macrophage inflammatory
protein (MIP)-1␤ (CCL4) and monocyte chemoattractant protein-1 (CCL2) mRNA and protein. Although fMLP stimulated both
sustained Ca2ⴙ mobilization and phosphorylation of extracellular signal-regulated kinase (ERK), these responses to C3a or C5a
were transient. However, transient expression of C3a receptors in HMC-1 cells rendered the cells responsive to C3a for sustained
Ca2ⴙ mobilization and MIP-1␤ production. The fMLP-induced chemokine production was blocked by pertussis toxin, PD98059,
and cyclosporin A, which respectively inhibit Gi␣ activation, mitgen-activated protein kinase kinase-mediated ERK phosphorylation, and calcineurin-mediated activation of NFAT. Furthermore, fMLP, but not C5a, stimulated NFAT activation in HMC-1
cells. These data indicate that chemoattractant receptors induce chemokine production in HMC-1 cells with a selectivity that
depends on the level of receptor expression, the length of their signaling time, and the synergistic interaction of multiple signaling
pathways, including extracellular signal-regulated kinase phosphorylation, sustained Ca2ⴙ mobilization and NFAT
activation. The Journal of Immunology, 2000, 165: 7215–7223.
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depends on the level of receptor expression, the length of signaling
time, and the synergistic interaction of ERK phosphorylation, sustained Ca2⫹ mobilization and NFAT activation.

Materials and Methods

ized overnight with 10 g of RNA samples. The hybridized RNA was
treated with RNase and purified according to the manufacturer’s recommendations. The samples were electrophoresed in 6% polyacrylamide gels,
the gels were dried and exposed, and protected fragments were quantified
by phosphorimager analysis.

Assay of chemokine protein production by ELISA

FMLP, wortmannin, bisindolylmaleimide (GF 109203X), PD98059, fluphenazine, and A23187 were purchased from Calbiochem (La Jolla, CA).
[3H]fMLP (53.6 Ci/mmol) was obtained from New England Nuclear (Boston, MA). [␥-32P]ATP was purchased from ICN Radiochemicals (Irvine,
CA). Recombinant C5a and 8-(4-chlorophenylthio)-cAMP (cpt-cAMP)
were purchased from Sigma (St. Louis, MO). PMA, indo-1/AM, and pluoronic acid were obtained from Molecular Probes (Eugene, OR). Rabbit
anit-ERK-1, anti-ERK-2, and anti-phospho-Elk-1 Abs were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA), and rabbit anti-phospho-ERK
Ab was purchased from New England Biolabs (Beverly, MA). 12CA5 Ab
was obtained from Roche (Indianapolis, IN). Purified C3a was obtained
from Advanced Research Technologies (San Diego, CA). The ptx was
obtained from List Biologicals (Campbell, CA). The ECL Western blotting
analysis kit was purchased from Amersham (Arlington Heights, IL). All
tissue culture reagents were purchased from Life Technologies
(Gaithersburg, MD).

For measurement of chemokine protein release, HMC-1 cells were resuspended in fresh complete growth medium (1 ⫻ 106/ml), and cells were
stimulated with C3a, C5a, or fMLP for 6 h (unless otherwise stated). Supernatants were collected from centrifuged samples and were stored frozen
at ⫺80°C until analysis. Chemokine protein levels were quantified by
sandwich ELISA using matched Ab pairs. ELISA plates (Costar, Cambridge, MA) were coated with 400 ng/well of capture Ab (14215.41 for
MIP-1␣ (R&D Systems, Minneapolis, MN), 24006.111 for MIP-1␤ (R&D
Systems), 6217.11 for IL-8 (R&D Systems), and B69 –2 for MCP-1
(PharMingen)) in PBS overnight at 4°C, blocked with blocking buffer (PBS
containing 1% BSA, 5% sucrose, and 0.05% NaN3) for 2 h at room temperature, and washed with washing buffer (0.05% Tween-20 in PBS). Samples (100 l) and standards were incubated for 2 h at room temperature,
washed, and incubated with 20 ng/ml polyclonal biotinylated Abs to
MIP-1␣ (R&D Systems), MIP-1␤ (R&D Systems), IL-8 (R&D Systems),
or MCP-1 (PharMingen) for 2 h at room temperature. After washing, 0.1
ng/ml streptavidin-HRP (Zymed, South San Francisco, CA) was added for
20 min at room temperature, washed, and developed with tetramthylbenzidine peroxidase substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) for 20 min. The peroxidase reaction was stopped by adding 0.5
volumes of 1 M phosphoric acid. The plate was read at 450 nm in an
ELISA plate reader (Anthos, Durham, NC).

Cell culture and transfection
The human mast cell line HMC-1 was established from a patient suffering
from mast cell leukemia and was provided by Dr. J. H. Butterfield (Mayo
Clinic, Rochester, MN). HMC-1 cells were cultured in IMDM supplemented with 10% FCS, glutamine (2 mM), penicillin (100 U/ml), and
streptomycin (100 g/ml). For transfection, cells were washed twice in
Earle’s modified Eagle’s medium supplemented with 50 mM HEPES and
20% FBS. Cells were resuspended in the same medium at a density of 5 ⫻
107/ml, and 1 ⫻ 107 cells were electroporated (Gene Pulser, Bio-Rad,
Hercules, CA) at 250 V and a capacitance of 500 microfarad in the presence of a mammalian expression vector pcDNA3 (10 g) containing
cDNA encoding hemagglutinin (HA)-tagged fMLP receptor (HA-FR) (13).
The culture medium was replaced with fresh medium containing 1 mg/ml
geneticin (G418) 24 h after transfection. Two weeks after electroporation,
the antibiotic resistant cells were analyzed for cell surface expression of
HA-FR by flow cytometry, and the top 3% of cells expressing the receptor
were sorted by FACS and cultured for use in this study.

Radioligand binding
Binding of [3H]fMLP to intact HMC-1 cells expressing HA-FR was conducted on 1 ⫻ 106 cells in 200 l of HEPES-buffered saline supplemented
with 1% BSA at 4°C for 4 h. Cells were collected by vacuum filtration on
Whatman GF/C filters (Clifton, NJ) and washed four times with ice-cold
saline, then dried filters were counted in scintillation fluid (13).

Calcium measurements
HMC-1 cells (3 ⫻ 10 ) were loaded with 1 M indo-1/AM in the presence
of 1 M pluronic acid for 30 min at room temperature. Cells were washed
and resuspended in 1.5 ml of HEPES-buffered saline. Intracellular Ca2⫹
measurements were conducted in a Perkin-Elmer fluorescence spectrophotometer (model 650-19, Norwalk, CT) with an excitation wavelength of
355 nm and an emission wavelength of 410 nm. Maximum and minimum
fluorescence values were determined in the presence of 0.1% Triton X-100
and 20 mM Tris-HCl (pH 8.0)/5 mM EGTA, respectively. Intracellular Ca2⫹ concentrations were calculated using the following formula:
[Ca2⫹] ⫽ Kd (F ⫺ Fmin)/Fmax ⫺ F) (13, 14).
6

Analysis of cytokine mRNA expression by RNase protection
assay (RPA)
HMC-1 cells (8 ⫻ 106/3 ml of complete growth medium) were exposed to
fMLP, C3a, or C5a, incubated at 37°C for 1–15 h, collected, centrifuged,
and washed with PBS. Total RNA was extracted and quantitated by absorbance at 260 nm. Cytokine mRNAs encoding IL-2, IL-3, IL-4, IL-5,
IL-6, IL-7, IL-8, IL-9, IL-10, IL-13, IL-14, IL-15, TNF-␣, TNF-␤, LT␤,
IFN-␤, IFN-␥, TGF-␤1, TGF-␤2, TGF-␤3, G-CSF, M-CSF, GM-CSF,
stem cell factor, leukocyte inhibitory factor, oncostatin M, lymphotaetin,
MCP-1, MIP-1␣ (CCL3), MIP-1␤, I-309 (CCL1), IFN, ␥-inducible protein
of 10 kDa (IP-10, CXCL10), and RANTES (CCL5) were detected using
the RiboQuant Multiprobe RPA template sets hCK-1, hCK-3, hCK-4, and
hCK-5 (PharMingen, San Diego, CA). 32P-labeled riboprobes were generated according to the manufacturer’s recommendations and were hybrid-

Phosphorylation of ERK-1/ERK-2
HMC-1 cells (1 ⫻ 106/sample) were stimulated with fMLP (1 M) or C3a
(10 nM) in HEPES-buffered saline, and the reaction was stopped at different time periods by the addition of a 3-fold excess of ice-cold PBS
containing 1 mM sodium orthovanadate. Cells were harvested by centrifugation and resuspended in 50 l of lysis buffer of the following composition: 150 mM NaCl, 50 mM Tris (pH 8.0), 1.0% Nonidet P-40, 0.5%
deoxycholate, 0.1% SDS, 5 mM EDTA, 10 mM sodium fluoride, 10 mM
sodium pyrophosphate, 1 mM sodium orthovanadate, 10 g/ml leupeptin,
100 g/ml 1-chloro-3-tosylamido-4-phenyl-2-butanone, 50 g/ml
1-chloro-3-tosylamido-7-amino-2-heptanone, and 10 g/ml PMSF. The
samples were centrifuged (10,000 ⫻ g, 10 min) to remove insoluble debris,
and the supernatant was mixed with an equal volume of 2⫻ SDS sample
buffer and heated to 90°C for 10 min. Samples were electrophoresed in
10% SDS-polyacrylamide gels and transferred onto a nitrocellulose filter.
The filter was treated with 3% nonfat milk in PBS and incubated with an
Ab specific for phosphorylated ERK-1/ERK-2. The reaction was detected
by enhanced chemiluminescence. The membrane was stripped and reprobed with an Ab that reacts with unphosphorylated ERK-1 or ERK-2.

Construction of HA-C3aR and transient transfection in
HMC-1 cells
A nucleotide sequence encoding the nine-amino acid HA peptide (YPY
DVPDYA) was inserted between the N-terminal initiator methionine and
the second amino acid of C3aR by PCR. The 5⬘ oligonucleotide, in a 5⬘-3⬘
order, contained six miscellaneous bases, six bases encoding BamHI, three
bases encoding methionine, 27 bases encoding the HA tag, and 27 bases
complementary to the cDNA of the C3aR encoding aa 2–10 of the receptor.
The 3⬘-oligonucleotide was complementary to the C-terminal seven amino
acids and a stop codon with a 5⬘ HindIII and ligated into a mammalian
expression vector, pRK5 (13). Transient transfection of HMC-1 cells with
empty vector (mock) or vector containing cDNA encoding HA-C3aR was
performed as described above for FR, but the cells were used 16 –18 h after
transfection. Mock or C3aR-transfected cells were incubated with 12CA5
Ab followed by FITC-labeled goat anti-mouse IgG. The cells were washed,
and receptor expression was analyzed by flow cytometry.

Nuclear extracts and EMSA
Nuclear extracts were prepared according to the method of Shreiber et al.
(15) with some modification. HMC-1 cells (1 ⫻ 107) were treated with or
without fMLP (1 M) or C5a (100 nM) for 1 h at 37°C. Cells were washed
in PBS and resuspended in 10 ml of ice-cold buffer A (10 mM HEPES (pH
7.6), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.75 mM spermidine,
1 mM DTT, 0.5 mM PMSF, 1 g/ml aprotinin, 2 g/ml leupeptin, and 2
g/ml pepstatin) and incubated for 15 min on ice. Nonidet P-40 was added
from a 10% stock solution to a final concentration of 0.6%, and the sample
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Results
Characterization of expressed HA-FR in HMC-1 cells
HMC-1 cells, which endogenously express receptors for C3a and
C5a at low levels, were stably transfected with cDNA encoding
HA-FR. The transfectants were analyzed for their ability to bind
[3H]fMLP and to mobilize Ca2⫹ in response to fMLP. Saturation
binding studies revealed the presence of 54,354 ⫾ 3,478 binding
sites/cell, which compares to 55,000 –120,000 binding sites for
natively expressed receptors in human neutrophils (17, 18). As
shown in Fig. 1A, fMLP stimulated a dose-dependent increase in
peak Ca2⫹ mobilization in transfected HMC-1 cells with an EC50
value of 80 nM, which is identical with the EC50 value reported for
fMLP-stimulated degranulation in rat basophilic leukemia (RBL2H3) cells expressing HA-FR (13). C3a and C5a also stimulated
dose-dependent increases in Ca2⫹ mobilization, but with EC50 values of 0.1 and 3.3 nM, respectively (Fig. 1A). Although the peak
intracellular Ca2⫹ mobilizations to all three ligands were similar in
magnitude, there were remarkable differences in their ability to
activate a sustained Ca2⫹ mobilization. Responses to all three
stimulants reached a peak within 5 s after stimulation. However,
C3a and C5a-induced Ca2⫹ mobilizations returned to basal levels
within 2–3 min after stimulation. In contrast, fMLP-induced Ca2⫹
mobilization remained elevated for the duration of the experiment
(up to 15 min). Ptx (100 ng/ml for 16 h) blocked Ca2⫹ mobilization to C3a, C5a, and both the initial Ca2⫹ spike as well as the
sustained response to fMLP (data not shown).
Expression of chemokine mRNA and protein by HMC-1 cells
To determine the effects of signaling through chemoattractant receptors on cytokine expression, transfected HMC-1 cells were
stimulated for different time periods with a concentration of chemoattractant that resulted in maximal Ca2⫹ mobilization; C3a (10
nM), C5a (100 nM), or fMLP (1 M) and cytokine mRNAs were
quantified by RPA. Resting HMC-1 cells expressed no mRNAs
encoding cytokines IL-2, IL-3, IL-4, IL-5, IL-7, IL-9, IL-10, IL13, IL-14, IFN-␥, oncostatin M, TGF-␤2, TGF-␤3, G-CSF, GMCSF, or stem cell factor as determined by RPA, and stimulation
with C3a, C5a, or fMLP did not induce their expression (not

FIGURE 1. Calcium mobilization by fMLP, C3a, and C5a in HMC-1
cells. HMC-1 cells expressing FR (3 ⫻ 106/sample), were loaded with
indo-1 and stimulated with different concentrations of C3a, C5a, or fMLP,
and peak Ca2⫹ mobilization was determined (A). The basal response in the
absence of chemoattractant was 199 ⫾ 8 nM (n ⫽ 36). Points are the
mean ⫾ SE of three experiments. B, Tracing for Ca2⫹ in response to
optimal concentrations of fMLP (1 M), C3a (10 nM), and C5a (100 nM).
Data are representative of three experiments.

shown). HMC-1 cells constitutively expressed low levels of mRNAs encoding the cytokines IL-6, IL-15, leukocyte inhibitory factor, lymphotoxin ␤, M-CSF, and TGF-␤1, but their expression was
not changed by stimulation with C3a, C5a, or fMLP. For chemokines,
neither unstimulated nor chemoattractant-stimulated HMC-1 cells
expressed mRNAs for lymphotactin, I-309, INF-␥-inducible protein
of 10 kDa, or RANTES (Fig. 2A). HMC-1 cells did express low levels
of MIP-1␤, MCP-1, and IL-8 transcripts. Stimulation with fMLP, but
not C3a or C5a, for 3 h caused an up-regulation of MIP-1␤ and
MCP-1 mRNAs (31 ⫾ 17-fold for MIP-1␤ and 10 ⫾ 2-fold for
MCP-1; n ⫽ 4; Fig. 2, A–C). This effect of fMLP was due to the
activation of its receptor, because fMLP did not stimulate this response in untransfected cells (Fig. 2A). The effect of fMLP on MIP-1␣
mRNA expression in this assay was not clear, but C3a or C5a did not
cause up-regulation of mRNA for MIP-1␣ (Fig. 2A).
The ability of fMLP to up-regulate MIP-1␤ and MCP-1 mRNA
reached a maximum by 3 h after stimulation and returned to baseline levels by l4 h (Fig. 2, A and B). To determine whether the
up-regulation of mRNA by fMLP resulted in protein production,
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was vortexed for 10 s. Samples were centrifuged at 3,000 rpm for 10 min
at 4°C, and the nuclei were resuspended in 10 ml of buffer C (20 mM
HEPES (pH 7.6), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT,
0.5 mM PMSF, 1 g/ml aprotinin, and 2 g/ml pepstatin). Suspensions
were agitated for 30 min at 4°C, and nuclear extracts were separated from
debris by centrifugation at 15,000 ⫻ g for 15 min at 4°C. Nuclear extracts
were frozen at ⫺70°C in aliquots containing 20% glycerol.
NFATc and AP-1 consensus and mutant double-stranded oligonucleotides were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Top-strand sequences are NFATc consensus site 5⬘-CGCCAAAGAGGA
AAATTTGTTTCATA, NFATc mutant site 5⬘CGCCCAAAGCTTAAA
ATTTGTTTCATA, and AP-1 consensus site 5⬘-CGCTTGATGACTAC
AGCCGGAA. Annealed binding sites were radiolabeled using T4
polynucleotide kinase and [␥-32P]ATP. Radiolabeled oligonucleotides
were purified by electrophoresis through an 8% polyacrylamide gel, overnight elution from gel slices at 37°C, concentration using an Elutip-d
(Schleicher & Schuell, Keene, NH), and ethanol precipitation. EMSAs
were performed as described previously (16) with some modifications. Nuclear extracts (3 g) were incubated with 1 g of poly(dI-dC) carrier in a
25-l reaction mix containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1
mM DTT, 1 mM EDTA, and 5% glycerol for 30 min either at room temperature (to test Ab inhibition) or at 4°C (to test oligonucleotide competition). For Ab inhibition experiments, 0.2 g of goat affinity-purified antiNFATc (SC-1149X, Santa Cruz Biotechnology) or goat control IgG was
included in the incubation. For oligonucleotide competition experiments,
unlabeled oligonucleotides (250 fmol) were included in the incubation.
Labeled binding site probes (5 fmol, ⬃5– 6 ⫻ 104 cpm) were then added
for an additional 20 min of incubation at 4°C. Samples were electrophoresed through a 4% polyacrylamide gel containing 22.5 mM Tris-borate
and 0.5 mM EDTA at 4°C.
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and protein release (Fig. 2E) was about 80 nM. Neither C3a (10
nM) nor C5a (100 nM) stimulated MIP-1␤ production in HMC-1
cells either at the mRNA or protein level (Fig. 2, A, B, and D).
Neither C3a nor C5a, up to a concentration of 1 M, stimulated
MIP-1␤ production (data not shown). In human lung mast cells
and HMC-1 cells, MCP-1 is released into the supernatant in a
constitutive manner (19). We also found that incubation of HMC-1
cells with medium alone for 6 h resulted in production of MCP-1
to a level of 195 ⫾ 26 pg/106 cells. Stimulation of cells with fMLP
for 6 h resulted in a net increase of 730 ⫾ 143 pg/106 cells. Under
this condition, neither fMLP, C3a, nor C5a stimulated secretion of
MIP-1␣, RANTES, or IL-8 proteins in HMC-1 cells (data not
shown).

FIGURE 2. GPCR-mediated chemokine production in HMC-1 cells as
determined by RPA and ELISA. A, For RPA, HMC-1 cells expressing FR
(8 ⫻ 106 in 3 ml of medium) were stimulated with fMLP (1 M), C3a (10
nM), or C5a (100 nM) for 0, 1, 3, 6, and 14 h. For a control, untransfected
cells were also stimulated with fMLP, C3a, and C5a for 3 h. Total cellular
RNA was isolated and hybridized with 32P-labeled riboprobes. Following
RNase digestion, the samples were resolved by SDS-PAGE, and the gels
were exposed in a phosphorimager. B, Time course of fMLP-induced
MIP-1␤ mRNA up-regulation in HMC-1 cells. Quantitation of mRNA for
MIP1-␤ was performed with ImageQuant software and is expressed as a
percentage of GAPDH. C, Dose-response curve of MIP-1␤ mRNA expression at 3 h in response to varying doses of fMLP. Data are expressed as a
percentage of GAPDH. For the assay of chemokine protein production,
HMC-1 cells (1 ⫻ 106 cells/1 ml medium) were incubated with fMLP (1
M), C3a (10 nM), or C5a (100 nM) for different time periods (D) or with
different concentrations of FMLP for 6 h (E). The samples were centrifuged, and supernatants were used to determine MIP-1␤ by ELISA. The
data shown are representative of three experiments.

supernatants from fMLP-, C3a-, and C5a-stimulated HMC-1 cells
were tested for MIP-1␤ and MCP-1 proteins by ELISA. Unstimulated cells secreted little or no MIP-1␤. However, stimulation of
HMC-1 cells with fMLP resulted in a time- and dose-dependent
increase in MIP-1␤ protein production (Fig. 2, D and E). The
production of MIP-1␤ was maximal at 6 h after stimulation and
declined thereafter (Fig. 2D). As for Ca2⫹ mobilization, the EC50
for both fMLP-induced MIP-1␤ mRNA up-regulation (Fig. 2C)

FR couples to Gi-like G proteins in leukocytes (13, 18, 20). To test
the role of signaling through Gi␣ proteins in chemokine gene expression, we incubated HMC-1 cells with ptx (100 ng/ml, overnight), which inhibits signaling through Gi␣, and stimulated cells
with fMLP (1 M) for 2 h (mRNA) and 6 h (chemokine release).
Ptx had no effect on basal responses, but almost completely abolished both fMLP-stimulated mRNA induction and protein release
(Fig. 3). To determine which signal transduction pathways may be
involved in the generation of chemokines by GPCR activation, we
tested the effects of inhibitors of protein kinase C (bisindolylmaleimide), PI3 kinase (wortmannin), mitogen-activated protein
kinase kinase (MEK) (PD98059), and a membrane-permeable
cAMP analogue, cpt-cAMP, an activator of PKA. Bisindolylmaleimide had no effect on fMLP-induced chemokine production at
either the mRNA or protein level (Fig. 3). Stimulation of cells with
PMA and the Ca2⫹ ionophore A23187 resulted in a much greater
level of MIP-1␤ production than that in fMLP-stimulated cells (net
increase of ⱖ2000 pg/106 cells compared with ⬃300 pg/106 cells).
Bisindolylmaleimide, which had no effect on fMLP-induced chemokine production, inhibited the response to PMA/A23187 by
⬎95% (not shown). Cpt-cAMP (1 mM) or PD98059 (100 M)
caused substantial inhibition of fMLP-induced MCP-1 and
MIP-1␤ mRNA up-regulation as well as MIP-1␤ protein release
(Fig. 3). Wortmannin partially blocked fMLP-induced responses.
These data suggest that the ability of fMLP to stimulate the expression of MCP-1 and MIP-1␤ genes in HMC-1 cells requires
GPCR-mediated activation of MAPK, but not protein kinase C.
To further test the role of MAPK activation on chemokine production, the effect of fMLP on ERK phosphorylation was determined. HMC-1 cells were stimulated with fMLP (1 M) or C3a
(10 nM) for different time periods, and ERK phosphorylation was
determined by Western blotting using an Ab that specifically recognizes the phosphorylated ERK-1 and ERK-2. As shown in Fig.
4, fMLP caused phosphorylation of both ERK-1 and ERK-2. The
response reached a peak within 1 min after stimulation and was
sustained for up to 15 min. Although C3a also caused an increase
in ERK phosphorylation within 1 min, this response was transient
and returned to basal within 5 min after stimulation (Fig. 4). The
effects of the MEK-1 inhibitor PD98059 on fMLP-stimulated
MIP-1␤ production, phosphorylation of both ERK and its downstream effector Elk-1 were tested. As shown in Fig. 5, PD98059
inhibited fMLP-induced MIP-1␤ production, ERK and ELK-1
phosphorylation in a dose-dependent manner. Ptx had no effect on
basal ERK-2 phosphorylation, but substantially inhibited the response to fMLP (Fig. 6). Bisindolylmaleimide had no effect on
fMLP-induced ERK phosphorylation (Fig. 6) or chemokine production (Fig. 3). Surprisingly, neither wortmannin nor cpt-cAMP
inhibited fMLP-induced ERK-2 phosphorylation (Fig. 6) despite

Downloaded from http://www.jimmunol.org/ at Univ of Pennsylvania Library on September 29, 2022

Roles of G protein, protein kinase C, and ERK phosphorylation
in fMLP-induced MIP1-␤ production in HMC-1 cells

The Journal of Immunology

the fact that they blocked the chemokine response to fMLP (Fig.
3). These findings suggest that fMLP-induced chemokine production involves synergistic interaction of MAPK with another signaling pathway.
Role of extracellular Ca2⫹ on GPCR-induced MIP-1␤
production in HMC-1 cells
EGTA binds to extracellular Ca2⫹ and blocks Ca2⫹ influx in response to receptor stimulation. To test the role of extracellular
Ca2⫹ on fMLP-induced responses, HMC-1 cells were exposed to
EGTA (5 mM) before stimulation with the ligand. As shown in
Fig. 7, A and B, EGTA had no effect on the initial Ca2⫹ spike in
response to fMLP, but it blocked the sustained Ca2⫹ mobilization.
EGTA also completely inhibited fMLP-stimulated MIP-1␤ production (Fig. 7C). Calmodulin is a signaling molecule that mediates the effects of Ca2⫹ mobilization in many systems (21). To test
the role of Ca2⫹-mediated signaling on MIP-1␤ production,
HMC-1 cells were pretreated with a calmodulin inhibitor fluphenazine before stimulation with fMLP. As shown in Fig. 7C, fluophenazine almost completely blocked the response to fMLP.
Unlike FR, which are expressed on the surface of leukocytes at
high levels (50,000 –120,000 receptors/cell), C3aR and C5aR are
less abundant (3,000 –15,000 receptors/cell) (22). To test whether

FIGURE 4. Kinetics of fMLP- and C3a-induced ERK phosphorylation.
A HMC-1 cells were stimulated with fMLP (1 M) or C3a (10 nM), and
the reactions were stopped at different times by the addition of ice-cold
PBS. Cell pellets were lysed, proteins separated on a 10% SDS-polyacrylamide gel, and Western blotting was performed with an Ab that specifically
recognizes the phosphorylated forms of ERK-1 and ERK-2. Equal amounts
of protein loading were confirmed by stripping the membrane and performing a Western blot with ERK-2 Ab (not shown). B, The extent of
ERK-2 phosphorylation was expressed as the fold increase over the basal
unstimulated response. The data shown are the mean ⫾ SEM of four
experiments.

increasing the level of C3aR expression could result in C3a-induced chemokine production, HMC-1 cells were transiently transfected with vector alone (mock) or with cDNA encoding HAtagged C3aR. FACS analysis with 12CA5 Ab, which recognizes
the HA tag on the transfected receptor but does not bind to the
native receptor, revealed that ⬃40% of the cells expressed HAtagged C3aR (Fig. 8A). As expected, C3a stimulated a transient
Ca2⫹ mobilization in mock-transfected cells, but this response was
more sustained in cells transiently expressing C3aR (Fig. 8B). This
sustained Ca2⫹ response was associated with C3a-induced
MIP-1␤ production (Fig. 8C). Similar data were obtained with
HMC-1 cells transiently expressing C5aR (not shown). These findings suggest that the signaling pathway that synergizes with
MAPK activation for GPCR-induced chemokine production involves sustained Ca2⫹ mobilization.
Role of NFAT activation on fMLP-induced chemokine
production in HMC-1 cells
Given that elevation of intracellular calcium was a prominent feature of the response to fMLP, we hypothesized that Ca2⫹-dependent activation of calcineurin and, subsequently, NFAT may also
be involved in GPCR-induced chemokine gene expression. Certainly, Ag stimulation of T cells and mast cells causes calcineurin
activation (23). We first tested the effect of cyclosporin A (CsA),
a potent inhibitor of calcineurin, on fMLP-induced MIP-1␤ production. CsA (100 nM) inhibited fMLP-induced MIP-1␤ production by 80 ⫾ 3% (Fig. 9A). To test whether fMLP stimulates
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FIGURE 3. Effects of inhibitors on fMLP-stimulated chemokine production. HMC-1 cells expressing FR (8 ⫻ 106 in 3 ml medium for RPA (A)
or 1 ⫻ 106 cells/1 ml medium for ELISA (B)) were incubated with medium, ptx (100 ng/ml, overnight), bisindolylmaleimide (BIM; 10 M, 10
min), cpt-cAMP (1 mM, 10 min), wortmannin (100 nM, 30 min), or
PD98059 (100 M, 30 min) and stimulated WM; fMLP. A, The reaction
was continued for 3 h after stimulation. Total cellular RNA was isolated
and hybridized with 32P-labeled riboprobes. Following RNase digestion,
the samples were resolved by SDS-PAGE, and the gels were exposed in a
phosphorimager. B, The reaction was stopped 6 h after stimulation. The
samples were centrifuged, and supernatants were used to determine
MIP-1␤ production by ELISA. The data shown are representative of three
experiments.
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NFAT activity, nuclear extracts from untreated and fMLP-treated
HMC-1 cells were used to perform EMSA. As shown in Fig. 9B,
fMLP caused the up-regulation of a protein-DNA complex consistent with NFAT activation. This complex formed with a wildtype NFAT binding site (compare lanes 2 and 6), but not with a
mutant binding site (compare lanes 1 and 5). Moreover, unlabeled
wild-type competitor blocked the fMLP-induced complex formation, whereas the mutant competitor had no effect (Fig. 9B, lanes
7 and 8). To further test for specificity, the EMSA reaction was
performed in the presence of anti-NFAT or control Ab. AntiNFAT Ab inhibited formation of the fMLP-induced complex,
whereas the control Ab did not (Fig. 9C). Ag-stimulated cytokine
gene expression involves activation of both NFAT and AP-1.
Therefore, we determined whether fMLP also causes activation of
AP-1 in HMC-1 cells. For these experiments EMSA was first performed with nuclear extract from unstimulated HMC-1 cells. As
shown in Fig. 9D (lane 1), AP-1 binding activity was detected in
HMC-1 cell extracts. This activity represents AP-1, as incubation
with excess AP-1 oligonucleotide blocked formation of the protein-DNA complex, but a nonspecific control oligonucleotide had

no effect. Unlike its effect on NFAT, fMLP had no effect on the
AP-1 response (Fig. 9D). To test whether C5a stimulated transcription factor activation, nuclear extracts from fMLP- and C5astimulated HMC-1 cells were compared for their ability to stimulate NFAT and AP-1 activation. FMLP caused a 4.2 ⫾ 0.02-fold
increase in NFAT activity, whereas C5a had no effect.

Discussion
In this study we have used HMC-1, which endogenously expresses
receptors for C3a and C5a at low levels and generated stable transfectants expressing FR. We used this system as a model to study
the role of GPCR-mediated cytokine production in leukocytes. Using RPA, we initially screened for the ability of fMLP, C3a, and
C5a to induce mRNA accumulation of 33 cytokines. We found that
of these cytokines, mRNAs for MIP-1␤ and MCP-1 were up-regulated in response to fMLP, but not to C3a or C5a. This mRNA
up-regulation was associated with a time- and dose-dependent release of chemokines as measured by ELISA.
It is important to note that in leukocytes, FR are expressed at
much higher levels than C3aR or C5aR. For example, 50,000 –
120,000 FR are present on neutrophils (17, 18). In contrast, C3aR
expression in monocytes, neutrophils, eosinophils, and basophils
ranges from 3,000 to 10,000 copies/cell (22). Also, basophils, eosinophils, and HMC-1 cells express ⬃15,000 C5aR/cell. Although
most leukocytes express FR, C3aR, and C5aR, the ability of these
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FIGURE 5. Effect of PD98059 on fMLP-induced MIP-1␤ production,
ERK and ELK-1 phosphorylation. A, HMC-1 cells were incubated with
different concentrations of PD98059 for 30 min and were stimulated with
fMLP (1 M) for 6 h. MIP-1␤ production was determined by ELISA. The
data are expressed as the percentage of the fMLP-stimulated response
(350 ⫾ 23 pg/106 cells) after the basal level (50 ⫾ 4 pg/106 cells) was
subtracted. PD98059 had no significant effect on the basal response. B,
Cells were incubated in the absence or the presence of different concentrations of PD98059 and were exposed to buffer (⫺) or fMLP (⫹) for 3
min. Western blotting was performed with phospho-ERK Ab as described.
C, Stripping the membrane and performing Western blotting with ERK-2
Ab confirmed equal amounts of protein loading. D, The same membrane
was stripped again, and Western blotting was performed with a phosphoELK-1 Ab. Data shown are representative of three similar experiments.

FIGURE 6. Regulation of fMLP-induced ERK phosphorylation in
HMC-1 cells. Cells (1 ⫻ 106/ml) were incubated with medium (C/CONT),
ptx (100 ng/ml, overnight), bisindolylmaleimide (BIM; 10 M, 10 min),
cpt-cAMP (cAMP; 1 mM, 10 min), and wortmannin (WM; 100 nM, 30
min) and then exposed to buffer (⫺) or fMLP (1 M) and incubated for 3
min. The reactions were stopped by the addition of ice-cold PBS. Cell
pellets were lysed, proteins were separated on a 10% SDS-polyacrylamide
gel, and Western blotting was performed with phospho-ERK Ab (A). B,
The extent of ERK-2 phosphorylation was expressed as the fold increase
over the basal unstimulated response. The data shown are the mean ⫾ SEM
of four experiments.
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receptors to stimulate biological responses has been well documented only in human basophils. The differences in the biochemical and functional properties of the GPCRs described herein for
HMC-1 cells, which express 54, 354 ⫾ 3,478 FR/cell, are very
similar to those reported for the same receptors in basophils. For
example, as in basophils (1), fMLP stimulated a sustained Ca2⫹
mobilization, whereas the response to C5a was transient (Fig. 1).
Furthermore, fMLP causes leukotriene production in basophils,
whereas C3a or C5a has no effect (2, 24, 25). The findings in the
present study that C3a and C5a stimulate transient Ca2⫹ mobilization in HMC-1 cells and that overexpression of C3aR or C5aR
leads to both a sustained Ca2⫹ mobilization and MIP-1␤ production demonstrate that the ability of GPCR to stimulate chemokine
production depends on the level of receptor expression.
An interesting aspect of the present work was that although FR,
C3aR, and C5aR all couple to the same ptx-sensitive G protein, the
differences in their ability to stimulate chemokine production reflected the length of their signaling time. Thus, fMLP-stimulated
chemokine production was associated with both sustained Ca2⫹
mobilization and ERK phosphorylation. Furthermore, C3a and
C5a, which induced both transient Ca2⫹ mobilization and ERK

FIGURE 8. Effect of transient C3aR expression on C3a-mediated Ca2⫹
mobilization and MIP-1␤ production in HMC-1 cells. Cells were transiently transfected with empty vector (mock) or with cDNA encoding HAtagged C3aR (C3aR). A, FACS analysis was performed with 12CA5 Ab. B,
Indo-1-loaded mock-or C3aR-transfected cells were stimulated with C3a
(10 nM; at time zero) and intracellular Ca2⫹ mobilization was determined
for 4 –5 min. C, HMC-1 cells were incubated with C3a (10 nM) for 6 h, and
MIP-1␤ production was determined by ELISA. Data shown are representative of three similar experiments.

phosphorylation, did not stimulate chemokine production. Evidence that fMLP-induced ERK phosphorylation was necessary for
chemokine production was provided by the demonstration that ptx
and PD98059, which respectively block G protein and MAPK activation, inhibited fMLP-induced ERK phosphorylation and chemokine production. Furthermore, fMLP stimulated the phosphorylation ELK-1, which is a transcription factor that is activated by
ERK. In addition, PD980589 blocked fMLP-induced ELK-1 phosphorylation in a dose-dependent manner. These findings suggest
that fMLP-induced chemokine production in HMC-1 cells is mediated via signaling pathways that include sustained Ca2⫹ mobilization and ERK phosphorylation.
The mechanism by which fMLP stimulates ERK phosphorylation in HMC-1 cells is not known. It is generally accepted that
Gi-coupled receptors use the ␤␥ subunits of G protein to activate
MAPK via a mechanism involving the following pathway:
G␤␥3 Src3 Shc/Grb/SOS3 Ras3 Raf3 MEK3 ERK (26). In
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FIGURE 7. Effect of extracellular Ca2⫹ on fMLP-induced Ca2⫹ mobilization and MIP-1␤ production. HMC-1 cells were loaded with indo-1,
washed, and resuspended in HEPES buffer containing 1 mM Ca2⫹ (A) or
in the same buffer that was supplemented with EGTA (5 mM; B). FMLP
(1 M) was added (time zero), and intracellular Ca2⫹ levels were measured
for 4 –5 min. C, Cells were incubated with medium containing Ca2⫹ alone
or medium supplemented with EGTA (5 mM) or fluphenazine (FLU; 50
M) and stimulated with fMLP (1 M) for 6 h, and MIP-1␤ release was
determined by ELISA.
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neutrophils, PI3 kinase is involved in fMLP-induced ERK phosphorylation, possibly via its direct effect on MEK (G␤␥3 PI3
kinase3 MEK3 ERK) (8). Thus, cpt-cAMP and wortmannin,
which inhibit Raf-1 and PI3 kinase, respectively, block fMLPstimulated ERK phosphorylation in human neutrophils (8, 27). The
finding in the present study that neither wortmannin nor cAMP
blocked fMLP-induced ERK phosphorylation in HMC-1 cells is
inconsistent with a role for Raf or PI3 kinase in MAPK activation
in this cell line. This type of inconsistency has recently been reported for other receptors. For example, in CHO cells expressing
CXCR1 and CXCR2, IL-8-induced MAPK activation is mediated
independently of Raf or PI3 kinase (28). In Swiss-3T3 and COS-7
cells, epidermal growth factor and lysophosphatidic acid-induced
MAPK activities are mediated in a Raf-1-independent and a
cAMP-insensitive manner (29). In PC12 cells, Ras-dependent
MAPK activation also does not require PI3 kinase or Raf activation (30). These findings suggest the existence of a MEK kinase
different from classic Raf kinases that might be involved in ERK
phosphorylation in HMC-1 cells and other cell types. The identity
of this kinase and the mechanism by which fMLP activates ERK
phosphorylation remain to be determined.
An important and unexpected finding of the present study was
that although cpt-cAMP and wortmannin had no effect on fMLPstimulated ERK phosphorylation, they blocked chemokine production in response to fMLP. This raises the intriguing possibility that
fMLP-stimulated chemokine production involves synergistic interaction of ERK phosphorylation with another signaling pathway.
NFAT is a cytosolic transcription factor that regulates the activation of cytokine genes in Ag-stimulated T cells and mast cells (10,
11). Ag stimulation of these cells results in a Ca2⫹-dependent activation of the phosphatase calcineurin, which dephosphorylates
NFAT. This dephosphorylation allows NFAT to translocate to the
nucleus, where it combines with the AP-1 complex to regulate the
transcription of early cytokine genes (10, 23). The immunosuppressive drug CsA inhibits cytokine gene expression by blocking
calcineurin. Although recent studies have shown that GPCR could
activate NFAT in lymphoid (31) and microglial cells (32), its biological significance is not known. The demonstration herein that

CsA blocked fMLP-induced MIP-1␤ production indicated that the
signal needed to synergize with ERK phosphorylation to induce
chemokine production might be the activation of NFAT (Fig. 7).
This possibility was supported by the finding that fMLP, but not
C5a, stimulated NFAT activation in nuclear extracts of HMC-1
cells. Although NFAT regulates cytokine gene expression in Agstimulated mast cells and T cells, the present study demonstrates a
previously unrecognized role of this transcription factor in GPCRinduced chemokine production.
In summary, we have used a human mast cell line that natively
expresses C3aR and C5aR at low levels and generated stable transfectants expressing physiologic levels of FR as a model for GPCR
activation. Using this system we have shown that bacterial products such as fMLP can induce cells of innate immunity to produce
the proinflammatory chemokines MIP-1␤ and MCP-1 that may, in
turn, recruit other leukocytes to sites of infection. Furthermore, we
have shown that the selectivity of fMLP vs C3a or C5a to induce

FIGURE 10. Model for fMLP-induced chemokine gene expression in
HMC-1 cells. FMLP activates MAPK via a pathway that does not appear
to involve Raf. This response synergizes with NFAT activation for the
induction of chemokine gene expression.
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FIGURE 9. Role of NFAT in fMLP-stimulated chemokine production in HMC-1 cells. A, Cells were preincubated in the absence or the presence of CsA
(100 nM, 30 min) and exposed to medium (⫺) or fMLP (⫹) for 6 h. MIP-1␤ was determined by ELISA. B, Radiolabeled wild-type (WT) or mutant (M)
NFAT double-stranded oligonucleotides were incubated with nuclear extracts from control or fMLP-stimulated HMC-1 cells in the absence of competitor
or in the presence of a 50-fold molar excess of wild-type (WT) or mutant (M) competitors. DNA protein complex was resolved by electrophoresis. The
NFAT-containing complex is marked. C, Radiolabeled NFAT double-stranded oligonucleotides were incubated with nuclear extracts from fMLP-treated
HMC-1 cells in the presence of anti-NFAT or control polyclonal Abs. The NFAT-containing complex is marked. D, Radiolabeled AP-1 double-stranded
oligonucleotides were incubated as described in A to detect AP-1 binding. Competition was performed with a wild-type (WT) or nonspecific control (C)
oligonucleotide. The AP-1-containing complex is marked.
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chemokine production is due to the level of receptor expression,
the length of their signaling time, and the synergistic interaction of
ERK phosphorylation, sustained Ca2⫹ mobilization, and NFAT
activation (see model in Fig. 10).
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